Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
McKesson
Federal Trade Commission
Argus Health
Teva
Farmers Insurance
US Department of Justice
Merck
Chubb
AstraZeneca

Generated: October 17, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022428

« Back to Dashboard
NDA 022428 describes MOXEZA, which is a drug marketed by Novartis Pharms Corp and is included in one NDA. It is available from one supplier. There are four patents protecting this drug and one Paragraph IV challenge. Additional details are available on the MOXEZA profile page.

The generic ingredient in MOXEZA is moxifloxacin hydrochloride. There are eighteen drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the moxifloxacin hydrochloride profile page.

Summary for NDA: 022428

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:4
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Pharmacology for NDA: 022428

Ingredient-typeQuinolones

Suppliers and Packaging for NDA: 022428

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MOXEZA
moxifloxacin hydrochloride
SOLUTION/DROPS;OPHTHALMIC 022428 NDA Alcon Laboratories, Inc. 0065-0006 0065-0006-03 3 mL in 1 BOTTLE (0065-0006-03)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION/DROPS;OPHTHALMICStrengthEQ 0.5% BASE
Approval Date:Nov 19, 2010TE:AT2RLD:Yes
Patent:► SubscribePatent Expiration:Mar 29, 2020Product Flag?Substance Flag?Delist Request?Y
Patent:► SubscribePatent Expiration:Mar 29, 2020Product Flag?Substance Flag?Delist Request?Y
Patent:► SubscribePatent Expiration:May 29, 2029Product Flag?YSubstance Flag?Delist Request?

Expired Orange Book Patents for NDA: 022428

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis Pharms Corp
MOXEZA
moxifloxacin hydrochloride
SOLUTION/DROPS;OPHTHALMIC022428-001Nov 19, 2010► Subscribe► Subscribe
Novartis Pharms Corp
MOXEZA
moxifloxacin hydrochloride
SOLUTION/DROPS;OPHTHALMIC022428-001Nov 19, 2010► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Medtronic
Baxter
US Department of Justice
McKesson
Fuji
QuintilesIMS
Deloitte
Johnson and Johnson
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot